Recommend Target Statin Doses and Consider LDL After a Stroke

New evidence will spark questions about treatment targets for statins in patients with a prior ischemic stroke or TIA.

There's ongoing debate about whether to use target DOSES of statins shown to reduce CV risk...rather than titrating to an LDL GOAL.

Now data suggest treating to an LDL below 1.8 mmol/L instead of about 2.5 mmol/L prevents a recurrent CV event in about 1 in 42 ischemic stroke or TIA patients treated for 3.5 years.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote